Christopher Simms
Net worth: - $ as of 30/08/2026
Net worth: - $ as of 30/08/2026
Christopher Simms is Chief Commercial & Business Officer at 4D Molecular Therapeutics, Inc. starting in 2025.
Formerly, Mr. Simms was Chief Commercial Officer & Senior Vice President at IVERIC bio, Inc. Education includes an MBA from York University and an undergraduate degree from Memorial University of Newfoundland.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/03/2026 | 0 ( -.--% ) | - $ | 30/08/2026 |
| Companies | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 24/09/2024 |
| Companies | Position | End |
|---|---|---|
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
York University
York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial University of Newfoundland
Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions